Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Darshana Jani

Assessment of Clinical Immunogenicity of Inotuzumab Ozogamicin in Patients With Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia

AAPS Open
2018English

Related publications

Feasibility of Allografting in Patients With Advanced Acute Lymphoblastic Leukemia After Salvage Therapy With Inotuzumab Ozogamicin

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2013English

Initial Experience With CMC-544 (Inotuzumab Ozogamicin) in Pediatric Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia

Pediatric Blood and Cancer
OncologyChild HealthHematologyPerinatologyMedicinePediatrics
2013English

Indirect Treatment Comparison of Inotuzumab Ozogamicin Versus Blinatumomab for Relapsed or Refractory Acute Lymphoblastic Leukemia

Advances in Therapy
MedicinePharmacology
2019English

Cost Effectiveness of Blinatumomab Versus Inotuzumab Ozogamicin in Adult Patients With Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in the United States

PharmacoEconomics
Health PolicyPublic HealthOccupational HealthPharmacologyEnvironmental
2019English

Efficacy and Safety Analysis by Age Cohort of Inotuzumab Ozogamicin in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia Enrolled in INO-VATE

Cancer
Cancer ResearchOncology
2018English

Assessment of Puberty Processand Obesity in Children With Acute Lymphoblastic Leukemia (ALL) and Non-Hodgkin Lymphoma (NHL) Receiving Chemotherapy With or Without Radiotherapy Combined

Journal of North Khorasan University of Medical Sciences
2017English

Epoetin Alpha Decreases the Number of Erythrocyte Transfusions in Patients With Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, and Burkitt Leukemia/Lymphoma

Cancer
Cancer ResearchOncology
2011English

Pcn142 - Cost-Effectiveness Analysis of Inotuzumab Ozogamicin for the Treatment of Adults With Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in Bulgaria

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Chemoimmunotherapy With Inotuzumab Ozogamicin Combined With Mini-Hyper-Cvd, With or Without Blinatumomab, Is Highly Effective in Patients With Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in First Salvage

Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy